Can Pfizer's Dividend Survive the Patent Cliff? This $10.5 Billion Cancer Bet Could Hold the Answer.

Pfizer's net income is under pressure, and likely will be for the foreseeable future. Although its replenished pipeline and portfolio should help, Pfizer paid a sizable price for this growth.